From blood transfusion to patient blood management: a new paradigm for patient care and cost assessment of blood transfusion practice

Intern Med J. 2012 Mar;42(3):332-8. doi: 10.1111/j.1445-5994.2012.02717.x.


The ageing population in developed countries, including Australia, is putting increasing demands on blood transfusion services. With a falling donor pool there is likely to be a shortage of blood and blood products in the next 20 to 30 years unless there are significant changes in medical practice. The National Health and Medical Research Council/Australasian Society of Blood Transfusion Clinical Practice Guidelines on the Use of Blood Components from 2001 are being redeveloped by the National Health and Medical Research Council/Australian and New Zealand Society of Blood Transfusion as evidence-based patient-focused Patient Blood Management guidelines with the aim of improving patient outcomes by reducing inappropriate blood and blood product use and targeting therapies for improving the management of anaemia and coagulopathies.

MeSH terms

  • Aged
  • Anemia / drug therapy
  • Anemia / therapy
  • Australia
  • Blood Banks / economics*
  • Blood Banks / organization & administration
  • Blood Banks / supply & distribution
  • Blood Banks / trends
  • Blood Transfusion* / economics
  • Blood Transfusion* / statistics & numerical data
  • Costs and Cost Analysis*
  • Critical Care
  • Disease Management*
  • Evidence-Based Practice
  • Ferric Compounds / therapeutic use
  • Hematologic Diseases / therapy
  • Humans
  • Inappropriate Prescribing
  • Models, Theoretical
  • Patient-Centered Care
  • Perioperative Care
  • Plasma
  • Platelet Transfusion / economics
  • Platelet Transfusion / statistics & numerical data
  • Population Dynamics
  • Practice Guidelines as Topic
  • Prescriptions


  • Ferric Compounds
  • teferrol